OrthoAccel Technologies has started a clinical trial that evaluates the effect of AcceleDent on orthodontic tooth movement with clear aligners.
AcceleDent is the only FDA-cleared, class II medical device that speeds up orthodontic treatment by as much as 50%, according to the company.
Conducted at the University of Florida College of Dentistry, the prospective randomized controlled trial will follow patients for 12 weeks during their clear-aligner treatment with AcceleDent. The trial's principal investigator is Timothy Wheeler, DMD, PhD, a researcher and professor at the dental school.
"The purpose of this clinical trial is to evaluate how pulsatile forces produced through AcceleDent's SoftPulse Technology enable teeth to move faster," Dr. Wheeler said. "AcceleDent is such a groundbreaking innovation that there's a lot of interest in this study among orthodontists who want clinical evidence showing the product's potential benefits when used with clear aligners – faster tooth movement and reduced pain."
First introduced in the U.S. in 2012, AcceleDent is now available in more than 1,000 orthodontic locations throughout the U.S., according to the company.
